Chicago Pacific Founders has announced it has closed its debut fund.
The fund was oversubscribed at its $325 million hard cap.
Chicago Pacific Founders, based in Chicago, primarily invests in middle-market healthcare companies focusing on care service delivery.
The … Continue Reading
Thoma Bravo has announced it will acquire Imprivata for approximately $544 million.
Thoma Bravo, with offices in Chicago and San Francisco, is a PE firm that invests with a particular focus on application and infrastructure software and technology-enabled services.… Continue Reading
RoundTable Healthcare Partners has announced it has closed on its acquisition of Symmetry Surgical.
RoundTable is an operating-oriented firm focused exclusively on the healthcare industry. The company, based in Lake Forest, Ill., targets middle-market investments.
Symmetry Surgical, based in … Continue Reading
After a number of years of little HIPAA enforcement activity, the tides appear to be turning.
From September 2015 through April 2016, HIPAA settlements have averaged more than one a month. The dollar amounts involved are significant, ranging from $240,000 … Continue Reading
Bain Capital Private Equity will acquire a majority stake in Navicure, according to a Navicure press release.
Bain Capital, based in Boston, targets investments in healthcare and several other industries.
Navicure, based in Duluth, Ga., is a … Continue Reading
Leonard Green & Partners has announced it has closed the firm’s seventh PE investment fund with committed capital of $9.6 billion.
Leonard Green & Partners, founded in 1989 and headquartered in Los Angeles, seeks to invest in companies considered … Continue Reading
Blue Wolf Capital Partners has acquired National Home Health Care Corp. for $103 million, according to a Home Health Care News report citing a report from Capital One, which acted as administrative agent and lead bookrunner.
Blue Wolf, founded … Continue Reading
Private equity interest in the healthcare and life sciences sectors has continued to grow at a rapid pace during recent years. Many investors are becoming increasingly more knowledgeable and comfortable with investments involving direct patient care and reimbursement risk, while … Continue Reading
PACE operators may become the next target of interest for healthcare private equity investors following a first-of-its-kind acquisition of a PACE operator by private equity sponsor Welsh Carson Anderson & Stowe (WCAS), which plans to acquire Denver-based InnovAge for $206m.… Continue Reading
DocuTAP has announced that it has been acquired by Warburg Pincus.
DocuTAP, based in Sioux Falls, S.D., is a provider of urgent care technology, including software for electronic medical records, practice management and revenue cycle management.
Warburg Pincus, … Continue Reading
We have co-written a column with Scott Becker and Bart Walker, McGuireWoods partners, and Brooke Murphy, Becker’s Healthcare writer, on “Private Equity In Healthcare – A Review of 15 Niche Investment Areas” for Becker’s Hospital Review.
The article provides … Continue Reading
Council Capital has announced it has closed its third PE fund, Council Capital III, LP.
Council Capital, based in Nashville, is a healthcare PE firm with approximately $300 million of capital under management. It makes control and minority investments, … Continue Reading
Advent International has announced it will acquire a majority ownership interest in ATI Physical Therapy (ATI) from KRG Capital Partners.
ATI, headquartered in Bolingbrook, Ill., is a privately held healthcare company specializing in outpatient rehabilitation and adjacent healthcare services. … Continue Reading
Sverica Capital Management has announced it has closed its fourth private equity fund — Sverica Capital Partners Fund IV LP — at its hard cap of $275 million.
Sverica, a lower middle market PE firm with offices in Boston … Continue Reading
An increase in attention to and awareness of gender equality in private equity is a step in the right direction, experts say in a Law360 column.
As a recent Preqin report notes, only 10.5% of senior roles at North … Continue Reading
Synlogic has announced it has secured $40 million in series B financing.
Synlogic, based in Cambridge, Mass., is a biopharmaceutical company focused on the development of a class of therapeutics, called synthetic biotics. Synlogic’s two lead therapeutic programs are … Continue Reading
Our partner Scott Downing and I published a piece in AAOS Now last month that I thought investors might also be interested in.
We’ve written in the past about the steadily mounting interest by private equity investors in various physician … Continue Reading
In the past decade, the list of investors that have put their capital to work in the healthcare and life sciences industries has grown dramatically. Healthcare and life sciences offer some undeniable opportunities that continue to fuel investor interest, and … Continue Reading
“We’re looking for a symbiotic platform that will have a disruptive effect in a rapidly expanding ecosystem.” A private equity colleague of ours described this conversation, which he overheard at the most recent J.P. Morgan health care conference in San … Continue Reading
Retail clinics have grown substantially in number and popularity since their emergence in the early 2000s. Retail clinics are limited healthcare clinics that operate outside of physician offices and hospitals, typically in pharmacies, grocery stores, and ”big box” stores like … Continue Reading
It’s deal time! The 2016 JP Morgan Healthcare Conference has set the tone for another successful year for healthcare investing. A company’s financial health is a key factor in the underwriting process for any type of loan and, in the … Continue Reading
A September 2015 Consero survey of general counsels (GCs) from mid-size to large U.S. hospital and health systems provides some interesting insight into the top issues facing legal departments.
Highlights include the following:
… Continue Reading
- 94% of surveyed GCs said they are
Scholar Rock has announced it has secured $36 million in series B financing.
Scholar Rock, based in Cambridge, Mass., is a biotechnology company focused on developing drugs that selectively target supracellular activation of growth factors in the disease microenvironment. … Continue Reading
OrbiMed has announced the closing of its next venture capital fund with $950 million in limited partner commitments.
OrbiMed, headquartered in New York City, is an investment firm dedicated to the healthcare sector, with over $16 billion in assets … Continue Reading